The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $23,436.74 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has a potential value of $4,685.46 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,007.71 contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any particular business type....
The Defense Logistics Agency (DLA) awarded a $24,188.57 firm-fixed-price delivery order (SPE2DB24FZ4Q4) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of RINVOQ ER 15 MG TABLET UU 30S. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical products and medical supplies in support of the Department of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,084.60 contract is for the delivery of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,163.08 firm-fixed-price delivery order contract to Amerisource Bergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product, with a period of performance through September 13, 2024. This contract award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and Amerisource Bergen,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has a completion date of February 22, 2024 and a potential value of $12,030.84. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract was issued under...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...